New venture leverages an innovative sourcing model to help Banner Health ensure clinicians have access to life-saving drugs in short supply Read More »

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced that it has executed a pharmacy services agreement with Southside Specialty Pharmacy, further expanding access to treatment with Probuphine (buprenorphine) implant, Titan's novel maintenance treatment for Opioid Use Disorder (OUD) in eligible patients. Read More »

93% overall response (13 of 14 patients) and 71% complete response rates (10 of 14 patients) in follicular lymphoma grades 1 to 3a treated with REGN1979 5 mg to 320 mg Read More »

First and only once-daily, nebulized bronchodilator has potential to address unmet needs of China's nearly 100 million chronic obstructive pulmonary disease (COPD) patients Read More »

The Pharmacy Technician Certification Board (PTCB) has awarded grants to four state pharmacy associations in Connecticut, Iowa, North Dakota, and Tennessee to support projects that promote medication safety and advance the role of pharmacy technicians. Read More »

Loopback Analytics, a leading provider of data-driven solutions for hospital and health systems, announced today it has partnered with UC Davis Health specialty pharmacy services to help advance patient care and outcomes. Read More »

New Location Enhances Pharmacy and Support Services for all Healthcare Stakeholders Read More »

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Dupixent® (dupilumab), recommending to extend its approval in the European Union (EU) to include adolescents 12 to 17 years of age with moderate-to-severe atopic dermatitis who are candidates for systemic therapy. Read More »